Effective 1 November 2017, important changes were made to the safety monitoring and reporting requirements of research projects. These changes are consistent with the NHMRC's most recent guidance on safety monitoring and reporting in clinical trials involving therapeutic goods.
The following link will provide more information and a detailed map of the new reporting pathways. SCHN Research Ethics and Governance Office has applied these reporting pathways to all types of research projects.
Please use these SCHN specific reporting form templates for the reports outlined in the above link: